肝移植结果在一次性胆道胆炎和与代谢功能障碍相关的脂肪性肝病的结果重叠
Leandro Sierra1, Shahana Prakash2, Jamak Modaresi Esfeh3
1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
Annals of hepatology
|March 14, 2026
概括
主要胆道胆炎 (PBC) 与代谢功能障碍相关的脂肪性肝病 (MASLD) 显示了类似的移植存活率,除非糖尿病存在. 糖尿病显著降低了PBC/MASLD患者的长期存活率,需要集中查和管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 初级胆道胆炎 (PBC) 通常与代谢功能障碍相关的脂肪性肝病 (MASLD) 一起发生.
- 并发性MASLD对PBC患者肝移植 (LT) 结果的影响尚不清楚.
- 这项研究调查了MASLD如何影响PBC患者的肝移植结果.
研究的目的:
- 为了比较肝移植前和肝移植后的结果,在患有原发性胆道胆道炎 (PBC) 患者中,并没有并发性代谢功能障碍相关的脂肪性肝病 (MASLD).
- 确定影响这些患者群体移植成功和生存的因素.
主要方法:
- 对UNOS/OPTN数据库 (2002-2024) 进行了回顾性分析.
- 成年肝移植候选人与PBC或PBC/MASLD使用倾向性得分匹配进行了比较.
- 结果包括移植概率,等候名单中断,以及通过卡普兰-梅尔和考克斯回归分析的患者/移植存活率.
主要成果:
- 与仅使用PBC的患者相比,PBC/MASLD患者在移植前和移植后的BMI和糖尿病率更高.
- 在匹配后,只有PBC患者的等候名单中断率更高.
- 移植后的存活率在各组之间是相似的,但PBC/MASLD患者的糖尿病与显著较低的长期存活率 (10年:46%与76%相比).
- 在PBC/MASLD中,糖尿病是移植后死亡率最强的独立预测因素.
结论:
- 原发性胆道胆道炎 (PBC) 患者的等候名单中断率高于与同时发生代谢功能障碍相关的脂肪性肝病 (MASLD) 患者相比.
- 肝移植存活率在PBC和PBC/MASLD组之间是可比的,除非后者存在糖尿病.
- 糖尿病显著损害了PBC/MASLD患者移植后的长期结果,突出了优先进行糖尿病查和管理的必要性.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
312
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
312
01:29Chronic Pancreatitis II: Collaborative Care
456
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
456